2023

Value in Health, the official journal of ISPOR, announced the publication of new good practice guidelines for the design, conduct, analysis, and communication of quantitative benefit-risk assessments (qBRA) to support regulatory decision making of medical products.

ISPOR announced that its Board of Directors has appointed Rob Abbott as the Society’s new CEO and executive director after an extensive search process. Mr Abbott is assuming the role of ISPOR’s CEO today, succeeding Nancy S. Berg who is retiring.

Value in Health, the official journal of ISPOR, announced the publication of a series of articles describing important new research related to drug pricing globally. The series was published in the March 2023 issue of the journal.

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a new ISPOR Good Practices Report on patient-preference studies that also introduces the ISPOR Roadmap for Patient Preferences in Decision Making.

ISPOR announced the launch of a new educational resource for the field of health economics and outcomes research (HEOR)—HEOR Learning Lab™.

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research—announced the publication of a series of articles that promotes an understanding of patient-reported experience measures and their role in healthcare. The series was published in the January 2023 issue of Value in Health.

ISPOR announced that it has launched its HEOR News Desk, a new offering that selects and aggregates global news related to health economics and outcomes research (HEOR).

Value in Health, the official journal of ISPOR, announced the publication of a new template that provides a set of core recommendations for clear and reproducible real-world evidence study protocols.

ISPOR announced its plenary sessions and speakers for its ISPOR Europe 2022 conference. The conference will be held 6-9 November in Vienna, Austria and focused on the theme, “Collaborating Across Borders: Building and Using Evidence to Enable Access.”

Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology,” that details the challenges in improving patient access to next-generation DNA sequencing and proposes a plan of action to improve access.